£60.84

Springer Aktuelle Therapie gastrointestinaler Tumoren

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£61 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical
Generating forecast…
£60.84 £57.80 £59.01 £60.23 £61.45 £62.67 £63.88 08 July 2026 25 July 2026 11 August 2026 28 August 2026 14 September 2026

Price Distribution

Price distribution over 69 days • 1 price levels

Days at Price
69 days 0 17 35 52 69 £61 Days at Price

Price Analysis

Most common price: £61 (69 days, 100.0%)

Price range: £61 - £61

Price levels: 1 different prices over 69 days

Description

Eine signifikante Verbesserung der Heilungs- und Überlebensraten war in den letzten Jahren bei metastasierten gastrointestinalen Tumoren nicht zu beobachten. Umso wichtiger ist es, die vorhandenen therapeutischen Möglichkeiten sorgfältig zu evaluieren und die interdisziplinäre Zusammenarbeit weiter zu optimieren. Als ein für den Patienten höchst relevantes Ergebnis dieser Kooperation sind die jüngsten Ergebnisse der großen Studien zur adjuvanten Chemotherapie beim Kolonkarzinom und zur adjuvanten Chemo-/Strahlentherapie beim Rektumkarzinom zu werten, die kürzlich einen signifikanten Überlebensvorteil durch diese adjuvante Therapie nachgewiesen haben. In diesem Band werden für Oesophagus-, Magen-, Kolon-, Rektum-, Pankreas-, Gallen- und Analkarzinome die Ergebnisse der neuesten Studie präsentiert und für jeden Tumor die Wertigkeit von Chemotherapie, Chirurgie, Strahlentherapie und Immunmodulation bezüglich Prognose dargestellt.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 December 2011
Listed Since
22 September 2013

Barcode

No barcode data available

Similar Products You Might Like

Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)
87% match

Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)

Springer

£74.67 29 Aug 2026
Immunotherapy for Gastrointestinal Cancer
86% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.11 08 Aug 2026
New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors: 142 (Recent Results in Cancer Research, 142)
85% match

New Perspectives in Molecular and Clinical Management of Gastrointestinal Tumors: 142 (Recent Results in Cancer Research, 142)

Springer

£76.42 30 Aug 2026
Colon Cancer Diagnosis and Therapy: Volume 2
84% match

Colon Cancer Diagnosis and Therapy: Volume 2

Springer

£121.64 08 Aug 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
84% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.65 05 Aug 2026
Molecular Pathogenesis of Colorectal Cancer
83% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£108.01 06 Aug 2026
Modern Management of Cancer of the Rectum
83% match

Modern Management of Cancer of the Rectum

Springer

£72.71 29 Aug 2026
Multidisciplinary Management of Rectal Cancer: Questions and Answers
83% match

Multidisciplinary Management of Rectal Cancer: Questions and Answers

Springer

£124.50 06 Aug 2026
Multimodal Treatment of Recurrent Pelvic Colorectal Cancer (Updates in Surgery)
83% match

Multimodal Treatment of Recurrent Pelvic Colorectal Cancer (Updates in Surgery)

Springer

£85.91 31 Aug 2026
Early Gastrointestinal Cancers: 196 (Recent Results in Cancer Research, 196)
83% match

Early Gastrointestinal Cancers: 196 (Recent Results in Cancer Research, 196)

Springer

£80.64 15 Aug 2026
Early Gastrointestinal Cancers: 196 (Recent Results in Cancer Research, 196)
83% match

Early Gastrointestinal Cancers: 196 (Recent Results in Cancer Research, 196)

Springer

£103.20 08 Aug 2026
Clinical Management of Gastrointestinal Cancer: 18 (Cancer Treatment and Research, 18)
83% match

Clinical Management of Gastrointestinal Cancer: 18 (Cancer Treatment and Research, 18)

Springer

£166.84 30 Aug 2026
Management of Pancreatic Cancer and Cholangiocarcinoma
83% match

Management of Pancreatic Cancer and Cholangiocarcinoma

Springer

£103.27 18 Aug 2026
Management of Colorectal Cancers in Older People
82% match

Management of Colorectal Cancers in Older People

Springer

£80.67 03 Aug 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
82% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£40.34 06 Aug 2026
Chemotherapy and Radiotherapy of Gastrointestinal Tumors: 79 (Recent Results in Cancer Research, 79)
82% match

Chemotherapy and Radiotherapy of Gastrointestinal Tumors: 79 (Recent Results in Cancer Research, 79)

Springer

£78.02 12 Sep 2026
Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)
82% match

Surgery in Multimodal Management of Solid Tumors (Updates in Surgery)

Springer

£88.21 08 Aug 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
81% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£108.01 06 Aug 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
81% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£108.01 31 Aug 2026
Intestinal Tumorigenesis: Mechanisms of Development & Progression
81% match

Intestinal Tumorigenesis: Mechanisms of Development & Progression

Springer

£109.08 14 Sep 2026
Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)
81% match

Pancreatic Cancer: 177 (Recent Results in Cancer Research, 177)

Springer

£100.98 13 Aug 2026
Management des Lungenkarzinoms (Onkologie aktuell)
81% match

Management des Lungenkarzinoms (Onkologie aktuell)

Springer

£76.48 14 Sep 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
81% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£80.67 06 Aug 2026
Current Cancer Therapeutics
80% match

Current Cancer Therapeutics

Springer

£72.12 30 Jul 2026